TPST : Insider Transactions for Tempest Therapeutics, Inc

Company Profile Tempest Therapeutics is a biopharmaceutical company, focused on developing treatments for endocrine diseases. Co.'s three product candidates are: Livoletide (AZP-531), which is for the treatment Prader-Willi syndrome, a genetic endocrine disease usually characterized by hyperphagia, or insatiable hunger; nevanimibe (ATR-101), which is a potential treatment for patients with congenital adrenal hyperplasia, a monogenic adrenal disease that requires lifelong treatment with exogenous cortisol, often at high doses; and NK3R antagonist (MLE-301), which is a potential treatment of vasomotor symptoms commonly known as hot flashes and night sweats, in menopausal women.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-03-10	2023-12-08	2023-06-09	2022-06-09

Adjust Filter Settings

Records found: 227

Page 4 of 10

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Dipp Michelle

Chief Executive Officer

• • –

2016-05-10

$7.72

$153,628

I/I

19,900

420,961

2.66

Aldrich Richard

Director

– • –

2016-05-10

$7.72

$153,628

I/I

19,900

420,961

2.1

Malley Thomas

Director

– • –

2016-03-31

$0.00

D/D

1,396

126,970

Kozin Marc D

Director

– • –

2016-03-31

$0.00

D/D

1,020

22,564

Fisher Mary

Director

– • –

2016-03-31

$0.00

D/D

526

8,040

Aldrich Richard

Director

– • –

2016-03-31

$0.00

D/D

1,119

604,185

Dipp Michelle

Chief Executive Officer

• • –

2016-03-24

$9.23

$276,906

I/I

30,000

401,061

2.66

Aldrich Richard

Director

– • –

2016-03-24

$9.23

$276,906

I/I

30,000

401,061

2.1

Dipp Michelle

Chief Executive Officer

• • –

2016-03-23

$9.58

$290,334

I/I

29,800

371,061

2.66

Aldrich Richard

Director

– • –

2016-03-23

$9.58

$290,334

I/I

29,800

371,061

2.1

Dipp Michelle

Chief Executive Officer

• • –

2016-03-22

$10.53

$313,922

I/I

29,800

341,261

2.66

Aldrich Richard

Director

– • –

2016-03-22

$10.53

$313,922

I/I

29,800

341,261

2.1

Dipp Michelle

Chief Executive Officer

• • –

2016-03-21

$9.52

$310,591

I/I

30,000

311,461

2.66

Aldrich Richard

Director

– • –

2016-03-21

$9.52

$310,591

I/I

30,000

311,461

2.1

Aldrich Richard

Director

– • –

2016-03-18

$8.72

$260,743

I/I

29,900

281,461

2.1

Dipp Michelle

Chief Executive Officer

• • –

2016-03-18

$8.72

$260,743

I/I

29,900

281,461

2.66

Aldrich Richard

Director

– • –

2016-03-17

$7.79

$232,219

I/I

29,800

251,561

2.1

Dipp Michelle

Chief Executive Officer

• • –

2016-03-17

$7.79

$232,219

I/I

29,800

251,561

2.66

Aldrich Richard

Director

– • –

2016-03-16

$7.59

$228,302

I/I

29,529

221,761

2.1

Dipp Michelle

Chief Executive Officer

• • –

2016-03-16

$7.59

$228,302

I/I

29,529

221,761

2.66

Aldrich Richard

Director

– • –

2016-03-15

$7.80

$237,802

I/I

29,500

192,232

2.1

Dipp Michelle

Chief Executive Officer

• • –

2016-03-15

$7.80

$237,802

I/I

29,500

192,232

2.66

Aldrich Richard

Director

– • –

2016-03-14

$8.05

$241,602

I/I

30,000

162,732

2.1

Dipp Michelle

Chief Executive Officer

• • –

2016-03-14

$8.05

$241,602

I/I

30,000

162,732

2.66

Aldrich Richard

Director

– • –

2016-03-11

$7.50

$995,490

I/I

132,732

2.1

227 Records found	1 2 3 4 5 6 7 8 9 Next	Page 4 of 10

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: